VXLLF Vaxil Bio Ltd.Stock Price & Overview
Pink Current Info | $USD | Market Close
People Also Follow
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment. The company was founded in 2006 and is headquartered in Toronto, Canada.